Answers are grounded in this paper and cite their sources.
To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: